News

All News 2020 2019 2018 2017 2016

Researchers announced safety and effectiveness of ReciGen (interferon beta-1a 44 mcg manufactured by CinnaGen Co.) on COVID-19 patients

Happy New Year

CinnaGen ilac has been established in 2019

13June 2019 This company is the first full cycle manufacturing site to produce biosimilars in Turkey.

Happy New Year

CinnaGen Sponsors IranPharma Expo

23Sept. 2018 CinnaGen Co. is sponsoring IRANPHARMA EXPO, taking place at the Grand Musalla in Tehran.

CinnaGen in Iraq Health care Exhibition

28June 2018 CinnaGen participated in the Iraq Health Exhibition in Baghdad from June 28th to June 30th, 2018.

CinnaGen obtained a Halal Certificate

30May 2018 A first in the pharmaceutical industry for biologicals; CinnaGen has succeeded in obtaining a Halal certificate for its medicinal products.

Cinnagen in Duphat

03Mar. 2018 CinnaGen recently participated in Duphat, the biggest pharmaceutical event in the MENA region.

CinnaGen obtained GMP certification from EMA

24Feb. 2018 Iranian biosimilar company CinnaGen obtained GMP certification from EMA

CinnaGen, Exporter of the year

Dr. Hamedifar, a PharmaHero

30Jan 2017 Dr. Hamedifar is selected as PharmaHero by UBC.

CinnaGen ilaç

20Jan 2017 CinnaGen enters Turkey pharmaceutical market.

CinnoVex in medical reference books

Razi Research Festival on Medical Sciences

Launching the Iranian medicine "CinnoRA", in the presence of Minister of Health

Cooperation between CYPRUS and IRAN in health sector

CinnoRA is now available in the market

Liquid CinnoVex is now available in the market

27Aug. 2016 CinnoVex (Interferon beta-1a) has a new formulation in liquid form.